Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.48 |
| ▸ | MAOB | P27338 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5797559 | 0.76 | ALPI (0.50) | MAOAMAOBTSHR | |
| SCHEMBL5925036 | 0.76 | ALPI (0.50) | MAOAMAOBTSHR | |
| Hydrochloric Acid SCHEMBL2480215 | 0.76 | MAOA (0.48) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL8647606 | 0.76 | MAOA (0.48) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL22562977 | 0.75 | ALDH1A1 (0.37) | MAOAMAOBMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL535991 | 0.74 | MAOA (0.47) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL18774257 | 0.73 | MAPT (0.42) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL7055858 | 0.72 | MAOA (0.45) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL5924980 | 0.72 | TSHR (0.50) | MAOAMAOBLMNAMAPTSMN1; SMN2 | |
| SCHEMBL24063980 | 0.71 | MAOA (0.44) | MAOAMAOBLMNAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3170493-B1 | FREEZE-DRIED PREPARATION CONTAINING HIGH-PURITY PTH AND METHOD FOR PRODUCING SAME | ASAHI KASEI PHARMA CORP (JP) | 2020-10-21 | — | — | EP | disclosed |